Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix
NCT ID: NCT00204997
Last Updated: 2019-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2002-09-30
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer
NCT00205010
Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer
NCT00500435
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma
NCT00595725
Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit
NCT00237562
Radical Trachelectomy for Women With Early Stage Cervical Cancer
NCT00813007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Laparoscopic Ovarian Transposition
Laparoscopic ovarian transposition
Laparoscopic ovarian transposition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic ovarian transposition
Laparoscopic ovarian transposition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Evidence of uterine involvement on MRI
* Evidence of distant mets on MRI
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David M Kushner, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Wisconsin Carbone Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2002-255
Identifier Type: -
Identifier Source: secondary_id
A532820
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/OBSTET & GYNECOL/OBSTET
Identifier Type: OTHER
Identifier Source: secondary_id
CO02702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.